Central precocious puberty: An overview of diagnosis, treatment, and outcome

Endocrinology and Metabolism Clinics of North America

Volumn 28, Issue 4, 1999, Pages 901-918

  Lee, P A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; HISTRELIN; LEUPRORELIN; NAFARELIN ACETATE; SEX HORMONE;

ADRENARCHE; BONE DENSITY; BONE MATURATION; DIAGNOSTIC TEST; GONADORELIN RELEASE; GONADORELIN TEST; GROWTH RATE; HORMONAL REGULATION; HUMAN; ONSET AGE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REVIEW; STEROID RELEASE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0032761556     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70108-0     Document Type: Article

References (38)

1. J.N. Anasti M.R. Flack J. Froelich A potential novel mechanism for precocious puberty in juvenile hypothyroidism J Clin Endocrinol Metab 80 1995 276
2. F. Antoniazzi F. Bertoldo G. Zamboni Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment Eur J Endocrinol 133 1995 412
3. A. Bar B. Linder E.H. Sobel Bayley-Pinneau method of height prediction in girls with central precocious puberty: Correlation with adult height J Pediatr 126 1995 955
4. A.M. Boot S.M.P.F. De Muinck Keizer-Schrama H.A.P. Pols Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty J Clin Endocrinol Metab 83 1998 370
5. R. Brauner L. Adan F. Malandry Adult height in girls with idiopathic true precocious puberty J Clin Endocrinol Metab 79 1994 415
6. E. Cacciari A. Cassio A. Balsamo Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray Arch Pediatr Adolesc Med 148 1994 1194
7. M. Cisternino E. Dondi M. Martinetti Exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation and evidence for CYP21B gene point mutations in true precocious puberty Clin Endocrinol 48 1998 555
8. H.L. Cohen M.F. Eisenberg J.O. Haller Ovarian cysts are common in premenarchal girls: A sonographic study of 101 children 2–12 years old AJR 159 1992 89
9. M.J. Elders C.R. Scott J.P. Frindik Clinical workup for precocious puberty Lancet 350 1997 457
10. J.W. Finkelstein E.J. Susman V.M. Chinchilli Effects of estrogen or testosterone on self-reported sexual responses and behaviors in hypogonadal adolescents J Clin Endocrinol Metab 83 1998 2281
11. M. Fontoura R. Brauner C. Prevot Precocious puberty in girls: Early diagnosis of a slowly progressing variant Arch Dis Child 64 1989 1170
12. M.E. Herman-Giddens E.J. Slora R.C. Wasserman Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research in Office Settings Network Pediatrics 99 1997 505
13. L. Ibáñez N. Potau M. Zampolli Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: Evidence from gonadotropin-releasing agonist testing Fertil Steril 67 1997 849
14. N. Jay M.J. Mansfield R.M. Blizzard Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists J Clin Endocrinol Metab 75 1992 890
15. A.-M.B. Jensen V. Brocks K. Holm Central precocious puberty in girls: Internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues J Pediatr 132 1998 105
16. R. Kauli A. Galatzer L. Korneich Final height girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue Horm Res 47 1997 54
17. K.O. Klein J. Baron K.M. Barnes Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone–releasing hormone agonist J Clin Endocrinol Metab 83 1998 2387
18. G.B. Kletter R.P. Kelch Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty J Clin Endocrinol Metab 79 1994 331
19. L. Lazar R. Kauli C. Bruchis Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response Eur J Endocrinol 133 1995 403
20. P.A. Lee Advances in the management of precocious puberty Clin Pediatr 33 1994 54
21. P.A. Lee Laboratory monitoring of children with precocious puberty Arch Pediatr Adolesc Med 148 1994 369
22. P.A. Lee S.F. Witchel The influence of estrogen on growth Curr Opin Pediatr 9 1997 431
23. P.K. Manasco O.H. Pescovitz P.P. Feuillan Resumption of puberty after long term luteinizing hormone–releasing hormone agonist treatment of central precocious puberty J Clin Endocrinol Metab 67 1988 368
24. P.K. Manasco O.H. Pescovitz S.C. Hill Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty J Pediatr 115 1989 105
25. C. Martí-Henneberg B. Vizmanos The duration of puberty in girls is related to the timing of its onset J Pediatr 131 1997 618
26. E.K. Neely L.K. Bachrach R.L. Hintz Bone mineral density during treatment of central precocious puberty J Pediatr 127 1995 819
27. E.K. Neely R.L. Hintz D.M. Wilson Normal ranges for immunochemiluminometric gonadotropin assays J Pediatr 127 1995 40
28. E.K. Neely D.M. Wilson P.A. Lee Spontaneous serum gonadotropin concentration assays J Pediatr 127 1995 40
29. K.E. Oerter P. Manasco K.M. Barnes Adult height in precocious puberty after long-term treatment with Deslorelin J Clin Endocrinol Metab 73 1991 1235
30. W. Oostdijk B. Rikken S. Schreuder Final height in central precocious puberty after long-term treatment with a slow release GnRH agonist Arch Dis Child 75 1996 292
31. D. Paul F.A. Conte M.M. Grumbach Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years J Clin Endocrinol Metab 80 1995 546
32. C. Pienkowski M.T. Tauber P. Pigeon Puberté précoce et syndrome des ovaires polykystiques: À propos de 13 observations Arch Pediatr 2 1995 729
33. R.L. Rosenfield Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs J Pediatr 124 1994 989
34. G. Saggese S. Beretlloni G.I. Baroncelli Reduction of bone density: An effect of gonadotropin releasing hormone analogue treatment in central precocious puberty Eur J Pediatr 152 1993 717
35. S. Salardi E. Cacciari B. Mainetti Outcome of premature thelarche: Relation to puberty and final height Arch Dis Child 79 1998 173
36. E.J. Susman J.W. Finkelstein V.M. Chinchilli The effect of sex hormone replacement therapy on behavior problems and moods in adolescents with delayed puberty J Pediatr 133 1998 521
37. T. Tanaka I. Hibi K. Koto A dose finding study of a super long-acting luteinizing hormone–releasing analog (Leuprolide Acetate Depot, TAP-144-SR) in the treatment of central precocious puberty Endocrinol Japan 38 1991 369
38. T. Tanaka H. Niimi N. Matsuo Dose of LHRH analog and growth velocity influence predicted final height in girls with central precocious puberty Clin Pediatr Endocrinol 6 1997 77